Role of cytokines in the pathogenesis of posterior capsule opacification

British Journal of Ophthalmology

Volumn 84, Issue 3, 2000, Pages 332-336

  Meacock, W R ^a   Spalton, D J ^a   Stanford, M R ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 6; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ARTICLE; CATARACT; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; LENS CAPSULE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

APOPTOSIS; CATARACT; CELL ADHESION; CELL DIFFERENTIATION; CELL DIVISION; CORNEA; CYTOKINES; EXTRACELLULAR MATRIX; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034100613     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.84.3.332     Document Type: Article

References (59)

1. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. [Revie] [430 refs] Surv Ophthalmol 1992;37:73-116.
2. Schaumberg DA, Dana MR, Christen WG, et al. A systematic overview of the incidence of posterior capsule opacification. Ophthalmology 1998;105: 1213-21.
3. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol 1993;111:1041-9.
4. Kappelhof JP, Vrensen GF. The pathology of after-cataract. A minireview. Acta Ophthalmol (Suppl) 1992;13-24.
5. McDonnell PJ, Zarbin MA, Green WR. Posterior capsule opacification in pseudophakic eyes. Ophthalmology 1983;90:1548-53.
6. McDonnell PJ, Rowen SL, Glaser BM, et al. Posterior capsule opacification. An in vitro model. Arch Ophthalmol 1985;103:1378-81.
7. Nishi O, Nishi K, Fujiwara T, et al. Types of collagen synthesised by the lens epithelial cells of human cataracts. Br J Ophthalmol 1995;79:939-43.
8. Kurosaka D, Kato K, Nagamoto T. Presence of alpha smooth muscle actin in lens epithelial cells of aphakic rabbit eyes. Br J Ophthalmol 1996;80:906-10.
9. Eshaghian J, Streeten BW. Human posterior subcapsular cataract. An ultrastructural study of the posteriorly migrating cells. Arch Ophthalmol 1980;98:134-43.
10. Wormstone IM, Liu CS, Rakic JM, et al. Human lens epithelial cell proliferation in a protein-free medium. Invest Ophthalmol Vis Sci 1997;38:396-404.
11. Duncan G, Wormstone IM, Liu CS, et al. Thapsigargin-coated intraocular lenses inhibit human lens cell growth. Nat Med 1997;3:1026-8.
12. Wormstone IM, Duncan G. Persistent lens cell activity throughout long-term culture of human capsular bags in protein-free medium. Invest Ophthalmol Vis Sci 1998;abstract:s212.
13. Massague J. The transforming growth factor-beta family. [Review] [257 refs] Annu Rev Cell Biol 1990;6:597-641.
14. Attisano L, Wrana JL, Lopez-Casillas F, et al. TGF-beta receptors and actions. [Review] [105 refs] Biochim Biophys Acta 1994;1222:71-80.
15. Dennis PA, Rifkin DB. Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor. Proc Natl Acad Sci USA 1991;88:580-4.
16. Schulz MW, Chamberlain CG, McAvoy JW. Inhibition of transforming growth factor-beta-induced cataractous changes in lens explants by ocular media and alpha 2-macroglobulin. Invest Ophthalmol Vis Sci 1996;37:1509-19.
17. Ellingsworth LR, Brennan JE, Fok K, et al. Antibodies to the N-terminal portion of cartilage-inducing factor A and transforming growth factor beta. Immunohistochemical localization and association with differentiating cells. J Biol Chem 1986;261:12362-7.
18. Gordon-Thomson C, de Iongh RU, Hales AM, et al. Differential cataractogenic potency of TGF-beta1, -beta2, and -beta3 and their expression in the postnatal rat eye. Invest Ophthalmol Vis Sci 1998;39:1399-409.
19. Kaji Y, Mita T, Obata H, et al. Expression of transforming growth factor beta superfamily and their receptors in the corneal stromal wound healing process after excimer laser keratectomy [letter]. Br J Ophthalmol 1998;82:462-3.
20. Pasquale LR, Dorman-Pease ME, Lutty GA, et al. Immunolocalization of TGF-beta 1, TGF-beta 2, and TGF-beta 3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci 1993;34:23-30.
21. Nishi K, Nishi O. Expression of transforming growth factor-beta and interleukin-8 messenger RNA in rat lens epithelial cells of human cataracts. Nippon yakurigaka Zasshi 1994;45:935-8.
22. Gordon-Thompson C. Differential cataractogenic potency of TGF-β1, -β2, and -β3 and their expression in the postnatal rat eye. Invest Ophthalmol Vis Sci 1998;39:1399-409.
23. Cousins SW, McCabe MM, Danielpour D, et al. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci 1991;32:2201-11.
24. Jampel HD, Roche N, Stark WJ, et al. Transforming growth factor-beta in human aqueous humor. Curr Eye Res 1990;9:963-9.
25. Wallentin N, Wickstrom K, Lundberg C. Effect of cataract surgery on aqueous TGF-beta and lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 1998;39:1410-18.
26. Border WA, Ruoslahti E. Transforming growth factor-beta in disease: the dark side of tissue repair. [Review] [79 refs] J Clin Invest 1992;90:1-7.
27. Tucker RF, Shipley GD, Moses HL, et al. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 1984;226:705-7.
28. Kurosaka D, Nagamoto T. Inhibitory effect of TGF-beta 2 in human aqueous humor on bovine lens epithelial cell proliferation. Invest Ophthalmol Vis Sci 1994;35:3408-12.
29. Desmouliere A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell. Biol 1993;122:103-11.
30. Kurosaka D, Kato K, Nagamoto T, et al. Growth factors influence contractility and alpha-smooth muscle actin expression in bovine lens epithelial cells. Invest Ophthalmol Vis Sci 1995;36:1701-8.
31. Bassols A, Massague J. Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem 1988;263:3039-45.
32. Nishi O, Nishi K, Fujiwara T, et al. Effects of the cytokines on the proliferation of and collagen synthesis by human cataract lens epithelial cells. Br J Ophthalmol 1996;80:63-8.
33. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989;264:1860-9.
34. Hynes RO. Integrins:a family of cell surface receptors. [Review] [50 refs] Cell 1987;48:549-54.
35. Ruoslahti E, Pierschbacher MD. New perspectives in cell adhesion: RGD and integrins. [Review] [65 refs] Science 1987;238:491-7.
36. Nishi O, Nishi K, Akaishi T, et al. Detection of cell adhesion molecules in lens epithelial cells of human cataracts. Invest Ophthalmol Vis Sci 1997;38: 579-85.
37. Olivero DK, Furcht LT. Type IV collagen, laminin, and fibronectin promote the adhesion and migration of rabbit lens epithelial cells in vitro. Invest Ophthalmol Vis Sci 1993;34:2825-34.
38. Nishi O, Nishi K, Mano C, et al. Inhibition of migrating lens epithelial cells by blocking the adhesion molecule integrin: a preliminary report. J Cataract Refract Surg 1997;23:860-5.
39. Liu J, Hales AM, Chamberlain CG, et al. Induction of cataract-like changes in rat lens epithelial explants by transforming growth factor beta [see comments]. Invest Ophthalmol Vis Sci 1994;35:388-401.
40. Kato K, Kurosaka D, Nagamoto T. Apoptotic cell death in rabbit lens after lens extraction. Invest Ophthalmol Vis Sci 1997;38:2322-30.
41. Burgess WH, Maciag T. The heparin-binding (fibroblast) growth factor family of proteins. [Review] [289 refs] Annu Rev Biochem 1989;58:575-606.
42. Gajdusek CM, Luo Z, Mayberg MR. Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J Cell Physiol 1993;157:133-44.
43. Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor: structural and biological properties. [Review] [34 refs] J Cell Physiol 1987; (Suppl 5):15-26.
44. Lovicu FJ, McAvoy JW. Localization of acidic fibroblast growth factor, basic fibroblast growth factor, and heparan sulphate proteoglycan in rat lens: implications for lens polarity and growth patterns. Invest Ophthalmol Vis Sci 1993;34:3355-65.
45. McAvoy JW, Chamberlain CG. Growth factors in the eye. [Review] [99 refs] Progr Growth Factor Res 1990;2:29-43.
46. McAvoy JW, Chamberlain CG. Fibroblast growth factor (FGF) induces different responses in lens epithelial cells depending on its concentration. Development 1989;107:221-8.
47. Tripathi RC, Millard CB, Tripathi BJ, et al. A molecule resembling fibroblast growth factor in aqueous humor. Am J Ophthalmol 1988;106:230-1.
48. Tripathi RC, Borisuth NS, Tripathi BJ. Detection, quantification, and significance of basic fibroblast growth factor in the aqueous humor of man, cat, dog and pig. Exp Eye Res 1992;54:447-54.
49. Hayashi N, Kato H. The change of immunohistochemical localization of basic fibroblastic growth factor around the lens capsule after extracapsular extraction. Acta Soc Ophthalmol Jpn 1991;95:621-4.
50. Oppenheim JJ, Kovacs EJ, Matsushima K. There is more than one interleukin 1. Immunol Today 1986;7:45-56.
51. Ferrick MR, Thurau SR, Oppenheim MH, et al. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vic Sci 1991;32:1534-9.
52. Nishi O, Nishi K, Imanishi M. Synthesis of interleukin-1 and prostaglandin E2 by lens epithelial cells of human cataracts. Br J Ophthalmol 1992;76:338-41.
53. Farrar WL, Humes JL. The role of arachidonic acid metabolism in the activities of interleukin 1 and 2. J Immunol 1985;135:1153-9.
54. Nishi O, Nishi K, Fujiwara T, et al. Effects of diclofenac sodium and indomethacin on proliferation and collagen synthesis of lens epithelial cells in vitro. J Cataract Refract Surg 1995;21:461-5.
55. Tetz MR, Ries MW, Lucas C, et al. Inhibition of posterior capsule opacification by an intraocular-lens-bound sustained drug delivery systemian:an experimental animal study and literature review. [Review] [49 refs] J Cataract Refract Surg 1996;22:1070-8.
56. Hirano T, Akira S, Taga T, et al. Biological and clinical aspects of interleukin 6 [see comments]. [Review] [73 refs] Immunol Today 1990;11:443-9.
57. Malecaze F, Chollet P, Cavrois E, et al. Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study. Arch Ophthalmol 1991;109:1681-3.
58. May LT, Torcia G, Cozzolino F, et al. Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun 1989;159:991-8.
59. Bito LZ. Species differences in the responses of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of experimental animals for eye research. [Review] [103 refs] Exp Eye Res 1984;39:807-29.